Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) is the most aggressive breast cancer subtype and is characterized by poor survival. Radiotherapy plays an important role in treating TNBC. The purpose of this study was to determine whether inhibiting the AMP-activated protein kinase (AMPK) and phosphatidylinosit...
Main Authors: | Jeremy Johnson, Zeta Chow, Dana Napier, Eun Lee, Heidi L. Weiss, B. Mark Evers, Piotr Rychahou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/5/1253 |
Similar Items
-
PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors
by: Zeta Chow, et al.
Published: (2021-05-01) -
Oleanolic acid combined with olaparib enhances radiosensitization in triple negative breast cancer and hypoxia imaging with 18F-FETNIM micro PET/CT
by: A-Lei Xu, et al.
Published: (2022-06-01) -
Radiosensitization: Studies and Modern Approaches to Cellular Radiosensitivity
by: Juan C. Alamilla-Presuel
Published: (2023-09-01) -
Xianlinglianxiafang Inhibited the growth and metastasis of triple-negative breast cancer via activating PPARγ/AMPK signaling pathway
by: Xiaojuan Yang, et al.
Published: (2023-09-01) -
Quercetin ameliorates chicken quality by activating the PI3K/PKB/AMPK signaling pathway in broilers
by: Mi Wang, et al.
Published: (2022-12-01)